EVISA - Who we are
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
National Cancer Institute: Cisplatin
Information - Pharmacy/Pharmacology
This page contains brief information about cisplatin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
See the complete list of deadlines!
TURCMOS2019: 4th International Turkish Congress on Molecular Spectroscopy
Ephesus, Kusadasi, AYDIN, TURKEY.
ICBIC 19: 19th International Conference on Biological Inorganic Chemistry
Goldschmidt 2019 conference session: Trace Elements Speciation: Novel Methodologies and Insights into Transformations Influencing their Global Biogeochemical Cycle
... more Events
What's new on EVISA's web site ?
EVISA welcomed its 13 Millionth User
Bromine Speciation in Human Serum
Efficiency of some papillomavirus vaccines is reduced in the presence of thimerosal
Selenoneine is a major selenium species in red blood cells of Inuit from Nunavik
... more News
You have forgotten your password ?
© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )